AstraZeneca
AZN
AZN
632 hedge funds and large institutions have $22.3B invested in AstraZeneca in 2019 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 179 increasing their positions, 208 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
9% more capital invested
Capital invested by funds: $20.4B → $22.3B (+$1.89B)
0.82% less ownership
Funds ownership: 34.88% → 34.06% (-0.82%)
14% less repeat investments, than reductions
Existing positions increased: 179 | Existing positions reduced: 208
Holders
632
Holding in Top 10
10
Calls
$103M
Puts
$71.3M
Top Buyers
| 1 | +$315M | |
| 2 | +$245M | |
| 3 | +$53.4M | |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
+$41.3M |
| 5 |
Renaissance Technologies
New York
|
+$35.5M |
Top Sellers
| 1 | -$542M | |
| 2 | -$293M | |
| 3 | -$106M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$86.9M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$63.3M |